Ascending single dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of PRA-027 administered orally to healthy Japanese females.

Trial Profile

Ascending single dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of PRA-027 administered orally to healthy Japanese females.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Jul 2009

At a glance

  • Drugs PRA 027 (Primary)
  • Indications Uterine leiomyoma
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Jun 2007 Status changed from initiated to recruiting.
    • 02 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top